Skip to main content
. 2017 Nov 23;8:855. doi: 10.3389/fphar.2017.00855

Table 3.

Single-component drugs targeting both extra- and intracellular factors.

Target Drug Clinical trialb Reference
Target or mechanism type Target or mechanism Organsa Drug Name Mechanism Class Disease Phase Reference/Trial identifierc
LOXd LOXL2d Liver, Kidney, Lung, Heart, Skin, Gut β-aminopropionitrile (BAPN) Inhibitor Small molecule Cardiac fibrosis Preclinical Martinez-Martinez et al., 2016
Simtuzumab (GS-6624) Inhibitor Monoclonal antibody Liver fibrosis; IPFd 2(completed); 2(terminated) NCT01452308; NCT01769196
ROSd NOX1d/NOX4 Liver, Kidney, Lung, Heart, Pancreas, Skin GM-CT-01 Inhibitor Polymer Liver fibrosis Preclinical Traber and Zomer, 2013
GR-MD-02 Inhibitor Polymer Liver fibrosis 2(completed) NCT02421094
GCS-100 Inhibitor Polymer Renal fibrosis 2(completed) NCT01843790
ROS GKT137831 Inhibitor Small molecule Liver fibrosis Preclinical Aoyama et al., 2012
N-acetylcysteine* Inhibitor Small molecule IPF Approved| Preclinical Demedts et al., 2005; Zhang et al., 2014
Mitoquinone Inhibitor Small molecule Liver fibrosis Preclinical Vilaseca et al., 2017
Salvianolic acid B* Inhibitor Small molecule Liver fibrosis; Renal fibrosis; IPF Preclinical Liu et al., 2002, 2016; Pan et al., 2011
Resveratrol* Inhibitor Small molecule Liver fibrosis 3(completed) NCT02030977
Vitamin (mimic) Liver, Kidney, Lung, Heart, Pancreas, Skin, Gut Pyridoxamine Inhibitor Small molecule Renal fibrosis 2(completed) NCT00320060
α-tocopherol Inhibitor Small molecule IPF Approved| Preclinical Deger et al., 2007
Collagen (mimic) Liver, Kidney, Lung, Skin IW001 Inhibitor Collagen IPF 1(completed) NCT01199887
*

Drug belongs to monomer extracted from natural products.

a

Organs that had study report of corresponding targets in fibrosis treatment.

b

Clinical trial resource are from http://Clinicaltrials.gov.

c

Trial Identifier is the clinical trail identifier of corresponding drug.

d

LOX, lysyl oxidase; LOXL2, lysyl oxidase homolog 2; IPF, idiopathic pulmonary fibrosis; ROS, reactive oxygen species; NOX1, NADPH oxidase 1.